Raffles Medical Group’s 1HFY2024 patmi down 48.8% y-o-y on cessation of Covid-19 activities

Raffles Medical Group has posted a 1HFY2024 ended June patmi of $30.6 million, down 48.8% y-o-y compared to the previous corresponding period. 

Revenue was also down by 1.4% y-o-y to $365.7 million. The lower revenue and patmi was due to the cessation of Covid-19 activities, which discontinued progressively in 1H2023.